1. Home
  2. MTEX vs INDP Comparison

MTEX vs INDP Comparison

Compare MTEX & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • INDP
  • Stock Information
  • Founded
  • MTEX 1993
  • INDP 2000
  • Country
  • MTEX United States
  • INDP United States
  • Employees
  • MTEX N/A
  • INDP N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • INDP Health Care
  • Exchange
  • MTEX Nasdaq
  • INDP Nasdaq
  • Market Cap
  • MTEX 14.5M
  • INDP 15.4M
  • IPO Year
  • MTEX 1999
  • INDP N/A
  • Fundamental
  • Price
  • MTEX $7.70
  • INDP $1.27
  • Analyst Decision
  • MTEX
  • INDP Strong Buy
  • Analyst Count
  • MTEX 0
  • INDP 1
  • Target Price
  • MTEX N/A
  • INDP $12.00
  • AVG Volume (30 Days)
  • MTEX 4.3K
  • INDP 23.5K
  • Earning Date
  • MTEX 11-05-2024
  • INDP 11-04-2024
  • Dividend Yield
  • MTEX N/A
  • INDP N/A
  • EPS Growth
  • MTEX N/A
  • INDP N/A
  • EPS
  • MTEX N/A
  • INDP N/A
  • Revenue
  • MTEX $122,380,000.00
  • INDP N/A
  • Revenue This Year
  • MTEX N/A
  • INDP N/A
  • Revenue Next Year
  • MTEX N/A
  • INDP N/A
  • P/E Ratio
  • MTEX N/A
  • INDP N/A
  • Revenue Growth
  • MTEX N/A
  • INDP N/A
  • 52 Week Low
  • MTEX $6.75
  • INDP $1.03
  • 52 Week High
  • MTEX $10.51
  • INDP $3.25
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 56.09
  • INDP 47.18
  • Support Level
  • MTEX $7.30
  • INDP $1.10
  • Resistance Level
  • MTEX $7.96
  • INDP $1.22
  • Average True Range (ATR)
  • MTEX 0.20
  • INDP 0.12
  • MACD
  • MTEX -0.00
  • INDP 0.01
  • Stochastic Oscillator
  • MTEX 69.15
  • INDP 66.67

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: